Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL3496901

Cc1c(N)c(Cl)nc2cc(C(F)(F)F)ccc12.N

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 2/20 0.40
BACE1 P56817 1/20 0.40
C1R P00736 1/20 0.38
EPHX2 P34913 1/20 0.38
SCN4A P35499 1/20 0.38
KIF11 P52732 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ILK Q13418 1/20 0.36
PARP1 P09874 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
PDE10A Q9Y233 1/20 0.36
NR4A2 P43354 1/20 0.36
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3496899 0.80 C1R (0.42) CTSDBACE1C1REPHX2SCN4A
SCHEMBL28795013 0.77 C1R (0.37) C1RKDM4EPARP1F7F3
SCHEMBL22806 0.76 DHODH (0.42) C1RKDM4EPARP1F7F3
Ammonia Solution, Strong SCHEMBL3496957 0.76 GABRP (0.43) KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL23040982 0.75 C1R (0.41) CTSDC1RKIF11KDM4EPARP1
SCHEMBL29636633 0.75 C1R (0.41) CTSDC1RKIF11KDM4EPARP1
SCHEMBL4772054 0.75 BACE1 (0.44) CTSDBACE1EPHX2SCN4AKIF11
Hydrochloric Acid SCHEMBL22807 0.75 DHODH (0.49) C1RKDM4ELMNACYP1A2CYP3A4
SCHEMBL1722672 0.75 PDE10A (0.40) CTSDBACE1EPHX2SCN4AKDM4E
SCHEMBL11985929 0.74 KDM4E (0.42) BACE1KIF11KDM4EPARP1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8513250-B2 Imidazolo-heteroaryl derivatives with antibacterial properties LABORATOIRE BIODIM (FR) 2013-08-20 US disclosed
US-20100130489-A1 IMIDAZOLO-HETEROARYL DERIVATIVES WITH ANTIBACTERIAL PROPERTIES MUTABILIS SA (FR) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130489-A1 IMIDAZOLO-HETEROARYL DERIVATIVES WITH ANTIBACTERIAL PROPERTIES DLAT, DLST, DNTT CTSD 2478/4885BACE1 1941/4885C1R 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.